Description
Kayaclav 1000 – Co-Amoxiclave combines 1000 mg of amoxicillin with 200 mg of clavulanic acid in each tablet, providing a broad-spectrum antibiotic action against various bacterial infections. This formulation helps to overcome resistance by inhibiting beta-lactamase enzymes produced by certain bacteria, making it effective for treating respiratory, urinary tract, and skin infections.
Key Benefits:
- Broad-Spectrum Antibiotic: Effective against a variety of gram-positive and gram-negative bacteria.
- Enhanced Efficacy: The addition of clavulanic acid protects amoxicillin from degradation, allowing for greater antibacterial activity.
- Convenient Dosage Form: Available in tablet form for easy administration.
Dosage: Follow your healthcare provider’s instructions regarding the appropriate dosage and duration of treatment based on the specific infection.
Choose Kayaclav 1000 for reliable and effective treatment of bacterial infections, ensuring comprehensive care for your health.